Spiros L Blackburn1, Christa B Swisher2, Andrew W Grande3, Alba Rubi1, Laura Zitella Verbick4, Aaron McCabe4, Shivanand P Lad5. 1. Department of Neurosurgery, University of Texas Health Sciences Center at Houston, Houston, Texas. 2. Department of Neurology, Duke University Medical Center, Durham, North Carolina. 3. Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota. 4. Minnetronix Inc, St. Paul, Minnesota. 5. Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
Abstract
BACKGROUND AND IMPORTANCE: The amount of subarachnoid blood and the presence of toxic blood breakdown products in the cerebrospinal fluid (CSF) have long been associated with poor outcomes in aneurysmal subarachnoid hemorrhage. The Neurapheresis™ system (Minnetronix Inc, St. Paul, Minnesota) has been developed to filter CSF and remove blood products, and is being investigated for safety and feasibility in the ExtracorPoreal FILtration of subarachnoid hemorrhage via SpinaL CAtheteR (PILLAR) study. We report the first case using this novel device. CLINICAL PRESENTATION: A 65-yr-old female presented with a ruptured left posterior communicating artery aneurysm. Following placement of a ventriculostomy and coil embolization of her aneurysm, the patient underwent placement of a lumbar dual lumen catheter for CSF filtration as part of the PILLAR study. In this case, a total of 9 h of filtration during 31 h of catheter indwelling resulted in 309.47 mL of processed CSF without complication. Computed tomography images demonstrated an interval reduction of subarachnoid hemorrhage immediately after filtration. The patient was discharged home on postbleed day 11 and at 30 d showed good recovery. CONCLUSION: Safety of the Neurapheresis procedure was confirmed in this first case, and we will continue to evaluate safety of the Neurapheresis system through the PILLAR trial.
BACKGROUND AND IMPORTANCE: The amount of subarachnoid blood and the presence of toxic blood breakdown products in the cerebrospinal fluid (CSF) have long been associated with poor outcomes in aneurysmal subarachnoid hemorrhage. The Neurapheresis™ system (Minnetronix Inc, St. Paul, Minnesota) has been developed to filter CSF and remove blood products, and is being investigated for safety and feasibility in the ExtracorPoreal FILtration of subarachnoid hemorrhage via SpinaL CAtheteR (PILLAR) study. We report the first case using this novel device. CLINICAL PRESENTATION: A 65-yr-old female presented with a ruptured left posterior communicating artery aneurysm. Following placement of a ventriculostomy and coil embolization of her aneurysm, the patient underwent placement of a lumbar dual lumen catheter for CSF filtration as part of the PILLAR study. In this case, a total of 9 h of filtration during 31 h of catheter indwelling resulted in 309.47 mL of processed CSF without complication. Computed tomography images demonstrated an interval reduction of subarachnoid hemorrhage immediately after filtration. The patient was discharged home on postbleed day 11 and at 30 d showed good recovery. CONCLUSION: Safety of the Neurapheresis procedure was confirmed in this first case, and we will continue to evaluate safety of the Neurapheresis system through the PILLAR trial.
Authors: Spiros L Blackburn; Andrew W Grande; Christa B Swisher; Erik F Hauck; Bharathi Jagadeesan; J Javier Provencio Journal: Stroke Date: 2019-07-26 Impact factor: 7.914
Authors: Syed M Adil; Beiyu Liu; Lefko T Charalambous; Musa Kiyani; Robert Gramer; Christa B Swisher; Laura Zitella Verbick; Aaron McCabe; Beth A Parente; Promila Pagadala; Shivanand P Lad Journal: Transl Stroke Res Date: 2019-03-13 Impact factor: 6.829
Authors: Mohammadreza Khani; Lucas R Sass; M Keith Sharp; Aaron R McCabe; Laura M Zitella Verbick; Shivanand P Lad; Bryn A Martin Journal: Fluids Barriers CNS Date: 2020-03-16
Authors: Tiffany Ejikeme; George C de Castro; Katelyn Ripple; Yutong Chen; Charles Giamberardino; Andrew Bartuska; Gordon Smilnak; Choiselle Marius; Jane-Valeriane Boua; Pakawat Chongsathidkiet; Sarah Hodges; Promila Pagadala; Laura Zitella Verbick; Aaron R McCabe; Shivanand P Lad Journal: Neurooncol Adv Date: 2020-04-18
Authors: Jamie K Wong; Anna K Roselle; Taylor M Shue; Serena J E Shimshak; Joseph M Beaty; Nadia M Celestin; Ivy Gao; Rose P Griffin; Merit E Cudkowicz; Saud A Sadiq Journal: Brain Commun Date: 2022-08-22
Authors: Lucas R Sass; Mohammadreza Khani; Jacob Romm; Marianne Schmid Daners; Kyle McCain; Tavara Freeman; Gregory T Carter; Douglas L Weeks; Brian Petersen; Jason Aldred; Dena Wingett; Bryn A Martin Journal: Fluids Barriers CNS Date: 2020-01-21